AAAAAA

   
Results: 1-8 |
Results: 8
DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION
Authors: PALVIMAKI EP MAJASUO H KUOPPAMAKI M MANNISTO PT SYVALAHTI E HIETALA J
Citation: Ep. Palvimaki et al., DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION, Psychopharmacology, 136(2), 1998, pp. 99-104
INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR
Authors: PALVIMAKI EP ROTH BL MAJASUO H LAAKSO A KUOPPAMAKI M SYVALAHTI E HIETALA J
Citation: Ep. Palvimaki et al., INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR, Psychopharmacology, 126(3), 1996, pp. 234-240
CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS
Authors: LAAKSO A PALVIMAKI EP KUOPPAMAKI M SYVALAHTI E HIETALA J
Citation: A. Laakso et al., CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS, Neuropsychopharmacology, 15(2), 1996, pp. 143-151
DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS
Authors: KUOPPAMAKI M PALVIMAKI EP HIETALA J SYVALAHTI E
Citation: M. Kuoppamaki et al., DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS, Neuropsychopharmacology, 13(2), 1995, pp. 139-150
5-HYDROXYTRYPTAMINE(2A) (5-HT2A) RECEPTOR DESENSITIZATION CAN OCCUR WITHOUT DOWN-REGULATION
Authors: ROTH BL PALVIMAKI EP BERRY S KHAN N SACHS N ULUER A CHOUDHARY MS
Citation: Bl. Roth et al., 5-HYDROXYTRYPTAMINE(2A) (5-HT2A) RECEPTOR DESENSITIZATION CAN OCCUR WITHOUT DOWN-REGULATION, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1638-1646
UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS
Authors: PALVIMAKI EP LAAKSO A KUOPPAMAKI M SYVALAHTI E HIETALA J
Citation: Ep. Palvimaki et al., UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS, Psychopharmacology, 115(4), 1994, pp. 543-546
DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION
Authors: SYVALAHTI EKG POHJALAINEN T KORPI ER PALVIMAKI EP OVASKA T KUOPPAMAKI M HIETALA J
Citation: Ekg. Syvalahti et al., DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION, Alcoholism, clinical and experimental research, 18(4), 1994, pp. 1029-1031
5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE
Authors: KUOPPAMAKI M PALVIMAKI EP SYVALAHTI E HIETALA J
Citation: M. Kuoppamaki et al., 5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE, European journal of pharmacology, 255(1-3), 1994, pp. 91-97
Risultati: 1-8 |